Belgian health ecosystem

Artificial intelligence is rapidly reshaping healthcare and life sciences. From improving clinical and operational decision-making to enhancing patient engagement, accelerating research, and supporting knowledge management, AI has the potential to transform how health organisations work.

However, the successful adoption of AI requires more than technology. It requires trust, responsible governance, regulatory alignment, data readiness, and a clear link to business and clinical value. 

PwC supports organisations in identifying high-value AI use cases, designing responsible and compliant AI frameworks, and implementing solutions that deliver measurable outcomes. We help clients move from experimentation to scalable adoption, ensuring AI is used safely, ethically, and effectively across the healthcare ecosystem.

Health organisations generate vast amounts of data, but many still struggle to turn that information into actionable insight. As care models evolve and decision-making becomes increasingly evidence-based, the ability to capture, connect, and use data effectively is becoming a strategic priority.

PwC helps organisations strengthen their data and analytics capabilities across the healthcare value chain. We support clients in building data-driven operating models, improving interoperability, enhancing evidence generation, and translating complex information into insights that support better decisions.

From real-world evidence and population health analytics to performance management and digital transformation, we help organisations unlock the value of health data in a secure, ethical, and impactful way.

Patients are playing a more active role in their health journeys. They expect care that’ is personalised, transparent, accessible, and digitally enabled. This shift is encouraging healthcare providers, payers, pharmaceutical companies, and medtech organisations to rethink how they engage with patients and deliver value.

PwC helps organisations design and implement patient-centred strategies that respond to changing expectations. We support the development of new engagement models, digital health solutions, and market access approaches that improve experience, adherence, and outcomes. 

By putting patients at the centre of transformation, organisations can build stronger relationships, improve trust, and create more sustainable models of care.

Belgium is a leading life sciences hub, with a strong concentration of pharmaceutical companies, biotech firms, medtech players, research centres, and clinical experts. The sector continues to evolve rapidly, driven by advances in precision medicine, advanced analytics, digital therapeutics, AI-enabled R&D, and new manufacturing technologies.

PwC supports life sciences organisations across the full value chain, from research and development to manufacturing, supply chain, commercial strategy, market access, and enterprise transformation. We help established companies adapt to changing market dynamics and support emerging medtech and biotech organisations as they scale. 

Our teams bring together industry expertise, regulatory understanding, technology capabilities, and operational experience to help life sciences organisations innovate with confidence and deliver long-term value.

Advanced therapies are redefining what is possible in medicine. Cell and gene therapies, personalised treatments, and next-generation biologics offer new hope for patients, while also creating new challenges for organisations developing, manufacturing, and delivering these therapies.

Belgium is emerging as an important European hub for advanced therapies and biomanufacturing. To realise this potential, organisations must address manufacturing scalability, supply chain complexity, workforce capabilities, regulatory readiness, and sustainable reimbursement models. 

PwC works with biotech companies, pharmaceutical organisations, research institutions, and ecosystem partners to help build the capabilities required for the next generation of therapies. We support clients in transforming operations, strengthening compliance, improving supply chain resilience, and preparing for sustainable growth.

Clinical development is undergoing significant change. New trial designs, decentralised approaches, digital tools, real-world evidence, and increasing patient involvement are reshaping how research is conducted. At the same time, organisations must manage rising complexity, cost pressures, regulatory expectations, and the need for faster access to innovation.

PwC supports pharmaceutical companies, biotechnology organisations, contract research organisations, and healthcare providers in transforming clinical development. We help clients optimise operating models, adopt digital and data-driven approaches, strengthen governance, and improve collaboration across research ecosystems. 

By modernising clinical development, organisations can accelerate innovation, improve trial efficiency, and bring new therapies to patients more effectively.